| CEO: | Peter Collins |
| Chairman: | Jan Groen |
| Non-Executive Dir: | Klaas de Boer, Benjamin Hart , Joseph (Joe) Eid M.D., Kim Oreskovic |
| Address: | 10 Nugent Road, Surrey Research Park, Guildford, Surrey, United Kingdom, GU2 7AF |
| Phone: | +44 (0)1483 343434 |
| Website: | http://cellbxhealth.com |
| Sector: | Support(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB0034330679 |
| Currency | UK Pounds |
| Share Price | 1.04p |
| Change Today | 0.043p |
| % Change | 4.29 % |
| 52 Week High | 16.50 |
| 52 Week Low | 0.85 |
| Volume | 8,368,870 |
| Shares Issued | 1,139.40m |
| Market Cap | £11.88m |
| Beta | 0.22 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 10:00 | 4,800,000 @ 0.95p |
| 09:20 | 3,168,198 @ 0.85p |
| 09:47 | 25,493 @ 0.93p |
| 09:43 | 93,846 @ 0.94p |
| 09:21 | 105,032 @ 0.94p |
| Chair | Jan Groen |
| CEO | Peter Collins |
You are here: research